Development of a radioimmunoassay for Pro-Leu-Gly-NH2 (PLG or MIF-I): evidence that PLG is not present in rat brain.
Pro-Leu-Gly-NH2 (PLG), which is the C-terminal tripeptide tail of oxytocin, has been reported to possess melanocyte-stimulating hormone (MSH)-release-inhibiting activity. Although it has been isolated from bovine hypothalamus, little is known about the CNS distribution of this peptide in other species. In this report, we describe the development of a radioimmunoassay which can be used to measure both PLG and oxytocin following chromatographic separation by high pressure liquid chromatography (HPLC). Using this method, we are unable to demonstrate the presence of any endogenous PLG in rat hypothalamus, preoptic area, pituitary, or eye tissue. However, synthetic PLG, which is added to tissue homogenates as an internal standard, is consistently recovered from all areas. We conclude that the PLG tripeptide is not present in the rat brain and thus cannot be the physiological regulator of MSH secretion.
D000818:Animals; D001923:Brain Chemistry; D003429:Cross Reactions; D005123:Eye / Q000032:analysis; D007031:Hypothalamus / Q000032:analysis; D007106:Immune Sera; D009075:MSH Release-Inhibiting Hormone / Q000032:analysis*; D008297:Male; D010121:Oxytocin; D010902:Pituitary Gland / Q000032:analysis; D011301:Preoptic Area / Q000032:analysis; D011863:Radioimmunoassay / Q000379:methods; D051381:Rats; D011919:Rats, Inbred Strains; D014018:Tissue Distribution
D007106:Immune Sera; D010121:Oxytocin; D009075:MSH Release-Inhibiting Hormone